Shu Lin
Program: Unspecified
Current advisor:
Undergraduate university: Vanderbilt University
Research summary
We are targeting LGALS1 or galectin-1 as a novel therapeutic target in the treatment of myeloproliferative neoplasm (MPN)
Graduate publications
He F, Laranjeira AB, Kong T, Lin S, Ashworth KJ, Liu A, Lasky NM, Fisher DA, Cox MJ, Fulbright MC, Antunes-Heck L, Yu L, Brakhane M, Gao B, Sykes SM, D’Alessandro A, Di Paola J, Oh ST. 2024 Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms. J Clin Invest, 343(3):e172256.